Skip to main content
TipRanks
Go Ultimate75% OFF

Hepion Pharmaceuticals (HEPA) Income Statement

790 Followers

Hepion Pharmaceuticals Income Statement

Last quarter (Q2 2026), Hepion Pharmaceuticals's total revenue was $0.00. In Q2, Hepion Pharmaceuticals's net income was $-1.25M. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 4.16M$ 19.35M$ 48.45M$ 45.49M$ 30.40M
Depreciation and Amortization$ 30.76K$ 30.76K$ 67.13K$ 77.46K$ 86.07K
$ -3.73M$ -14.88M$ -49.26M$ -45.00M$ -32.63M
$ -4.16M$ -19.35M$ -48.45M$ -45.49M$ -30.40M
$ -4.11M$ 3.18M$ -887.11K$ 404.83K$ -2.32M
$ -8.28M$ -16.16M$ -49.34M$ -45.08M$ -32.72M
$ -8.28M$ -13.19M$ -48.93M$ -42.20M$ -32.72M
Per Share Metrics
Basic EPS$ -0.88$ -107.35$ -616.07$ -594.75$ -465.52
Diluted EPS$ -0.88$ -107.35$ -616.07$ -594.75$ -465.52
Weighted Average Shares Outstanding9.41M122.89K79.42K76.23K70.29K
Weighted Average Shares Outstanding (Diluted)9.41M122.89K79.42K76.23K70.29K

Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

-60M-40M-20M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin